Congratulations to our CEO, President and Founder, Dr. Emil Kakkis,  on being honored as BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award recipient for his transformative work in rare diseases. Read more.

June 19, 2019
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases

June 17, 2019
Ultragenyx Expands Leadership Team and Promotes Erik Harris to Chief Commercial Officer

May 31, 2019
Ultragenyx to Present at Upcoming Investor Conferences